missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human C17orf71 (aa 322-454) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-55202 (PA5-55202. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Involved in nonsense-mediated decay (NMD) of mRNAs containing premature stop codons. Is recruited by release factors to stalled ribosomes together with SMG1 and SMG9 (forming the SMG1C protein kinase complex) and, in the SMG1C complex, is required to mediate the recruitment of SMG1 to the ribosome:SURF complex and to suppress SMG1 kinase activity until the ribosome:SURF complex locates the exon junction complex (EJC). Acts as a regulator of kinase activity. [UniProt]
Specifications
Specifications
| Accession Number | Q8ND04 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 55181 |
| Name | Human C17orf71 (aa 322-454) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1200011M11Rik; ABC2; Amplified in breast cancer gene 2 protein; C17orf71; C19H17orf71; CG6729 gene product; FLJ10587; FLJ23205; Protein SMG8; protein smg-8 homolog; RGD1306862; Smg8; smg-8 homolog, nonsense mediated mRNA decay factor; smg-8 homolog, nonsense mediated mRNA decay factor (C. elegans); SMG8 nonsense mediated mRNA decay factor; SMG8, nonsense mediated mRNA decay factor |
| Common Name | C17orf71 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction